↓ Skip to main content

Dove Medical Press

Circulating tumor cells (CTCs) in lung cancer: current status and future perspectives

Overview of attention for article published in Lung Cancer: Targets and Therapy, July 2010
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#43 of 128)

Mentioned by

patent
10 patents

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
39 Mendeley
Title
Circulating tumor cells (CTCs) in lung cancer: current status and future perspectives
Published in
Lung Cancer: Targets and Therapy, July 2010
DOI 10.2147/lctt.s6828
Pubmed ID
Authors

Fumihiro Tanaka, Kazue Yoneda, Seiki Hasegawa

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 3%
Unknown 38 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 13%
Student > Doctoral Student 5 13%
Professor > Associate Professor 4 10%
Student > Master 4 10%
Student > Ph. D. Student 4 10%
Other 8 21%
Unknown 9 23%
Readers by discipline Count As %
Medicine and Dentistry 11 28%
Agricultural and Biological Sciences 8 21%
Biochemistry, Genetics and Molecular Biology 5 13%
Veterinary Science and Veterinary Medicine 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 1 3%
Unknown 11 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2022.
All research outputs
#8,572,103
of 25,461,852 outputs
Outputs from Lung Cancer: Targets and Therapy
#43
of 128 outputs
Outputs of similar age
#37,983
of 104,035 outputs
Outputs of similar age from Lung Cancer: Targets and Therapy
#1
of 2 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 128 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,035 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them